Browsing by Author Kirkwood, John M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2006Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group.Millward, Michael; Bedikian, Agop Y.; Conry, Robert; DeConti, Ronald; Gore, Martin; Haluska, Frank G.; Hersey, Peter; Hersh, Evan M.; Kirkwood, John M; Pavlick, Anna C.; Pehamberger, Hubert; Trefzer, Uwe; MedicineBcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(29),2006,pp 4738-4745
2017Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manualLong, Georgina; Scolyer, Richard; Thompson, John; et al, Various; Faries, Mark; Gershenwald, Jeffrey E.; Haydu, Lauren E.; Hess, Kenneth R; Kirkwood, John M; Lazar, Alexander J.; McArthur, Grant A.; Ross, Merrick I; Sondak, Vernon; Northern Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: SurgeryMelanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual, CA A Cancer Journal for Clinicians, vol.67, 6, 2017,pp 472-492
2010Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases.Thompson, John; Balch, Charles M.; Byrd, David; Cascinelli, Natale; Cochran, Alistair J.; Coit, Daniel G.; Ding, Shouluan; Eggermont, Alexander; Gershenwald, Jeffrey E.; Johnson, Timothy; Kirkwood, John M; Leong, Stanley P.L.; McMasters, Kelly M; Mihm, Martin; Morton, Donald L.; Ross, Merrick I; Sondak, Vernon; Soong, Seng-Jaw; Central Clinical School: SurgeryMultivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases., Journal of Clinical Oncology (Online), vol.28, 14,pp 2452-2459
2012New challenges in endpoints for drug development in advanced melanomaHersey, Peter; Flaherty, Keith; Gogas, Helen; Kirkwood, John M; Middleton, Mark; Ribas, Antoni; Sondak, Vernon; Northern Clinical School: SurgeryNew challenges in endpoints for drug development in advanced melanoma, Clinical Cancer Research, vol.18, 2, 2012,pp 336-341
2003New TNM melanoma staging system: linking biology and natural history to clinical outcomesThompson, John; Atkins, Michael B.; Balch, Charles M.; Buzaid, Antonio C.; Cascinelli, Natale; Coit, Daniel G.; Fleming, Irvin D; Gershenwald, Jeffrey E.; Houghton, Alan; Kirkwood, John M; McMasters, Kelly M; Mihm, Martin F; Morton, Donald L.; Reintgen, Douglas S; Ross, Merrick I; Sober, Arthur; Soong, Seng-Jaw; Thompson, John A; Central Clinical School: SurgeryNew TNM melanoma staging system: linking biology and natural history to clinical outcomes, Seminars in Surgical Oncology, vol.21,(1),2003,pp 43-52
2009A Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic MelanomaKefford, Richard (Rick); Dar, Mohammed; Kathman, Steven; Kirkwood, John M; Laubscher, Kevin; Logan, Theodore F.; Mainwaring, Paul; Millward, Michael; Pavlick, Anna C.; Tarhini, Ahmad; Western Clinical School: Westmead Millennium InstituteA Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic Melanoma, Cancer, vol.115, 4,pp 859-868
2013Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic MelanomaKefford, Richard (Rick); Atkins, Michael B.; Flaherty, Keith T; Flaherty, Lawrence; Kirkwood, John M; Lee, Sandra J; Leming, Philip; Schuchter, Lynn; Zhao, Fengmin; Western Clinical School: Westmead Millennium InstitutePhase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma, Journal of Clinical Oncology, vol.31, 3, 2013,pp 373-379